Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Hologic (HOLX) PT Trimmed to $43 at Leerink Partners; Remains Top Pick
November 3, 2016 7:38 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating but lowered his price target on Hologic (NASDAQ: HOLX) to $43.00 (from $46.00) following results. Shares remain a top mid/large-cap pick.
Newitter commented, "following an F4Q beat and slightly better-than-expected cc top-line growth guide with... More
Hologic (HOLX) Tops Q4 EPS by 2c; Guides In-Line
November 2, 2016 4:03 PM EDTHologic (NASDAQ: HOLX) reported Q4 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $721.66 million.
GUIDANCE:
Hologic sees Q1 2017 EPS of $0.50-$0.51, versus the consensus of... More
